GDM: Prevention of GDM Diagnosis (2008)

Citation:
 
Study Design:
Class:
- Click here for explanation of classification scheme.
Quality Rating:
Research Purpose:

The aims of the present study were to:

  • evaluate dietary intakes of antioxidant vitamins, zinc, and selenium and serum levels of zinc and selenium in women with different degrees of gestational hyperglycemia
  • verify whether, after adjustment for multiple confounders, these micronutrients were independent predictors of gestational hyperglycemia.
Inclusion Criteria:
  • All women gave informed consent, all procedures were in accordance with the Helsinki Declaration as revised in 1983.
Exclusion Criteria:
Pregnant women known to have diabetes mellitus or a disease affecting glucose metabolism, active infections, chronic illness, or medical treatments (drugs or vitamin supplements) were excluded. 
Description of Study Protocol:

Recruitment

Cohort 1:

The study included all consecutive women screened from April 1999 - November 2000. All pregnant women attending the Department of Obstetrics and Gynecology of the University of Turin (Turin, Italy) are routinely screened with a 50-g oral glucose tolerance test (OGTT) at 24 - 28 wk of gestational age (as calculated by ultrasound examinations performed during the first trimester of gestation). All patients with a positive screening result (1-h serum glucose concentration >=7.8 M/L underwent a 3-h OGTT with 100 g glucose after 1 to 2 weeks. GDM was diagnosed when two serum glucose values were above the following levels: 5.3 mM/L after fasting, 10.0 mM/L at 1 h, 8.6 mM/L at 2 h, or 7.8 mM/L at 3 h according to established criteria . The category one abnormal value on the OGTT was defined when just one glucose value was higher than the noted cutoff levels.

Cohort 2:

To confirm the preliminary data obtained from the questionnaire analyses, serum levels of zinc and selenium were determined in a second cohort of women (24 to 30 wk of gestational age). This group included 71 consecutive hyperglycemic patients(42 with one abnormal value on the OGTT and 29 with GDM) in the same department from December 2000 to June 2001. All consecutive normoglycemic (n=123) during the first two weeks of this second period were enrolled as controls.

Design : Cohort

Blinding used :

Dietetic interviews were performed by 3 physicians who were trained in assessing habitual food patterns and blinded to the results of the OGTT; other physicians communicated the results of the OGTT to patients after the dietary interview. 

Intervention (if applicable):  Not applicable 

Statistical Analysis

  • The distribution of dietary intakes of micronutrients was tested with the Kolmogorov-Smirmov test and was normal.
  • Analysis of variance and chi-square test were used to compare means for continuous variables or frequencies for discrete variables
  • Multiple logistic regression analyses based on the maximum likelihood method were performed to evaluate the independent contribution of dietary intakes and serum levels of zinc and selenium on gestational hyperglycemia after adjusting for for multiple variables and for total energy intake according to literature.
  • Mutiple regression analyses were used to evaluate the association between birth weights of offspring of hyperglycemic women and maternal serum levels of trace elements after adjusting for maternal age, BMI, smoking status, and gestational age at birth.
Data Collection Summary:

Timing of Measurements Height was measured at the time of screening. Other timing of measurements were not specified.

Dependent Variables

  • Age (y)
  • Gestational age (wk)
  • BMI (kg/m2) - Height was measured at the time of screening,and patirnts supplied information on their prepregnancy weight. Body Mass index was calculated as prepregnancy weight (kg) divided by height squared (m2). 
  • Familial diabetes
  • Zinc (mg/d) - serum zinc levels were analyzed by flame atomic absorption spectrometry (4110ZL spectometer, Perkin-Elmer); coefficients of variation were 4.8% to 5.3%.*
  • Selenium (µ M/L) - serum selenium was determined by electrothermic atomic absorption spectrometry, Perkin-Elmer, Norwalk, CT,USA) with a graphic furnance and Zeemans background correction; coefficients of variation were 5.6% to 7.6%.*
  • Total energy (kcal/d) - the reliability of the reported energy intake was assessed by calculating the ratio of estimated energy intake on predicted basal metabolic rates using age-and sex-specific formulas derived by Schofield et al. A value of 0.88 which represented the 97.55 confidence interval (CI), was the cut-off point for under-reporting. The 18 under-reporters (3.6%), according to the above formula, were equally distributed across the three categories of glucose tolerance. 

* Analytical quality of serum levels of selenium and zinc was checked by analyzing standard reference materials (normal human serum) at two concentration levels (UTAK B1, level trace elements: normal-range code 66816 and high range code 66815). Results showed that analytical procedures were reliable.

Independent Variables

  • Age (y)
  • BMI (kg/m2)
  • Familial diabetes (%)*
  • Nulliparious (%)
  • Smoking (%)
  • Physical Activity (%): Light;Moderate;Vigorous
  • Total energy (kcal/d) - See Dietary Data Section
  • Serum Glucose - measured with the glucose oxidase method (Glucose-Analyser II, Beckman, Fullerton, CA, USA).
  • Zinc (mg/d) 
  • Selenium (µg/d)
  • Vitamin A (µg/d)
  • Vitamin C (mg/d- measured in first cohort only)

Dietary Data:

Detailed dietetic interviews were performed with all patients by means of a semiquantitative food-frequency questionnaire adapted from Willett and Coll (1985) with the following considerations:

  • subjects were European
  • searched for diet influences on the occurence of gestational hyperglycemia that was closely related to a short-lasting event pregnancy, and different from chronic conditions
  • an evaluation of dietary intake in the previous years was meaningless because women frequently cahnge their dietary habits in pregnancy (more "healthy habits, avoidance of some foods, etc).

An "ad hoc" questionnaire, designed by an expert dietitian, included a list of foods (60 items) most frequently consumed in northen Italy. Commonly consumed portions were specified.

Dietetic interviews were performed by 3 physicians who were trained in assessing habitual food patterns and blinded to the results of the OGTT; other physicians communicated the results of the OGTT to patients after the dietary interviews. The procedures utilized were as follow:

  • photographs were used to compare different portions for each item
  • patients were asked to indicate how often a day and how many days a week they consumed every specific food during the past week
  • data on cooking methods were also collected.

The food list completed by the physicians were entered into a software program (Food Meter, Medimatica s.r.I., Martinsicuro, Teramo, Italy,1990; modified in 1998 in the University of Turin according to food composition tables by the Italian National Institute of Nutrition). Subgroups of foods within the same category and with similar composition were collapsed in single items. Every item carried the weighted mean of macronutrients or minerals and vitamins. The database contained all foods consumed by the subjects.

 

Description of Actual Data Sample:

Initial N: The first cohort included 504 pregnant women(210 with hyperglycemia and 294 with normoglycemia). A second cohort of  71 hyperglycemic and 123 normoglycemic women,with a mean age and body mass index similar to those in the first cohort.

Attrition (final N):  as above

Age: See Table 1

Ethnicity: All subjects identified as European

Other relevant demographics:

Anthropometrics

Location:  University of Turin,Turin,Italy

Summary of Results:

In the two cohorts, patients with one abnormal value on the OGTT and GDM were older and had significantly higher BMI values before pregnancy (Table I).

Table 1: Clinical characteristics and nutritional data obtained by dietary assessment in the first cohort and characteristics of the second cohort of patients

 

Normoglycemia

      one abnormal value on the OGTT

GDM

P

First cohort        
Subjects

 294

 84

 126

 
Age (y)

 31.8±4.4

 33.0±4.9

 33.0±4.8

 0.02

BMI (kg/m2)

 23.6±4.6+

 26.0±5.5

 25.4±5.3

 <0.0001

Familial diabetes (%)*

 28+

 33

 41

 0.04

Nulliparous(%)

 62

 57

 55

 NS

Smoking (%)

 27

 25

 33

 NS

Physical Activity (%)        
Light

 21

 21

 24

 NS

Moderate

 65

 66

 67

 NS

Vigorous

 14

 13

 9

 NS

Total energy(kcal/d)

 2035±627

 2002±568

 1889±490

 NS

Zinc (mg/d)

 9.4±2.8+

 8.7±2.5

 8.5±2.4

 0.007

Selenium(µg/d)

 33.7±2.8+

 31.2±10.0

 30.5±10.6

 0.01

Vitamin A(µg/d)

 890.0±459.3

 837.7±399.4

 857.0±417.5

 NS

Vitamin E(mg/d)

 12.9±27.1

 17.6±52.6

 11.7±8.3

 NS

Vitamin C(mg/d)

 127.9±55.7

 117.6±52.3

 125.4±60.4

 NS

Second cohort        
Subjects

 123

 42

 29

 

Age (y)

 31.1±3.8+

 32.7±3.9

 33.5±3.9

 0.002

BMI (kg/m2)

 23.1±4.8

 25.1±5.3

 25.4±6.0

 0.02

Familial diabetes (%)*

 29

 33

 38

 NS

Nulliparous(%)

 61

 74

 58

 NS

Smoking (%)

 24

 27

 27

 NS

Physical activity (%)        
Light

 22

 20

 23

 NS

Moderate

 64

 65

 63

 NS

Vigorous

 13

 10

 12

 NS

BMI, body mass index; GDM, gestational diabetes; NS, not significant; OGTT, oral glucose tolerance test

*First-degree relative.

+p<0.01, patients with normoglycemia versus those with GDM.

♦ p<0.01, patients with normoglycemia versus those with one abnormal value on the OGTT.

In multiple logistic regression analysis, zinc and selenium dietary intakes were negatively associated with gestational hyperglycemia (one abnormal value on the OGTT and GDM; odds ratio=.089, 95% CI=0.82 to 0.96, P=0.002 for each increment in milligrams of daily zinc intake; odds ratio=0.97, 95%  CI=0.95 to 0.99, P=0.003 for each increment in micrograms of daily selenium intake) after adjusting for age, gestational age, familial diabetes, BMI before pregnancy, and total caloric intake (Table 2).

Table 2: Variables associated with gestational hyperglycemia* in multiple logistic regression

 

Variables

OR

95% CI

P

 First cohort      
 Age (y)

 1.09

 1.04-1.14

 0.0008

 Gestational Age (wk)

 0.93

 0.83-1.03

 NS

 BMI (kg/m2)

 1.12

 1.06-1.17

 <0.0001

 Familial diabetes♦

 1.23

 0.78-1.94

 NS

 Zinc (mg/d)

 0.89

 0.82-0.96

 0.002

 Selenium (µg/d)

 0.97

 0.95-0.99

 0.003

 Total energy (kcal/d)

 0.99

 0.98-1.02

 NS

 Second cohort      
 Age (y)

 1.20

 1.09-1.33

 0.0003

 Gestational age (wk)

 1.06

 0.97-1.15

 NS

 BMI (kg/m2)

 1.10

 1.02-1.18

 0.02

 Familial diabetes♦

 1.06

 0.48-2.34

 NS

 Zinc (µ M/L)

0.93

 0.91-0.96

 <0.0001

 Selenium (µ M/L)

 0.92

 0.8-0.95

 <0.0001

BMI, body mass index; CI, confidence interval; NS, not significant; OR, odds ratio

*Gestational diabetes and one abnormal value of the oral glucose tolerance test.

♦ First degree relatives.

Other Findings:

Patients with gestational hyperglycemia showed significantly lower serum levels of zinc and selenium (normoglycemia, one abnormal value of the OGTT, and GDM, respectively: 15.7±2.5µ M/l, P<0.0001 for serum zinc; 10.8±1.8 µM/L, 9.7±1.4µ M/L, and 8.8±1.3µ M/L, P<0.0001 for serum selenium).

 

 

Author Conclusion:

The data suggested a significant inverse association of dietary intakes and serum levels of zinc and selenium with gestational hyperglycemia.

Relaibility of data:

  • Total energy (kcal/d) - the reliability of the reported energy intake was assessed by calculating the ratio of estimated energy intake on predicted basal metabolic rates using age-and sex-specific formulas derived by Schofield et al. A value of 0.88 which represented the 97.55 confidence interval (CI),was the cut-off point for under-reporting. The 18 under-reporters (3.6%), according to the above formula, were equally distributed across the three categories of glucose tolerance. 
  • Analytical quality of serum levels of selenium and zinc was checked by analyzing standard reference materials (normal human serum) at two concentration levels (UTAK B1, level trace elements: normal-range code 66816 and high range code 66815). Results showed that analytical procedures were reliable.

Limitations:

  • Assessing intakes of microelements by a food frequency questionnaire does not represent a very sensitive method . The principle sources of zinc for the cohorts were meat, milk, cheese, and whole grains.
  • Dietary intake and serum levels of micronutrients were obtained from different cohorts. The inverse association between serum levels of selenium and zinc and gestational hyperglycemia obtained in the second group strengthened the data obtained in the first one by questionnaire analysis (lower dietary intake).
Funding Source:
University/Hospital: University of Turin
Reviewer Comments:

The limitations and critique of the study, as stated by the authors appear to be very appropriate.

Analytical longitudinal surveys refer to what epidemiologists term prospective or cohort studies. A Cohort Study is a study in which patients who presently have a certain condition and/or receive a particular treatment are followed over time and compared with another group who are not affected by the condition under investigation. Studies of this kind provide a better opportunity than one time cross sectional studies to examine whther certain behaviors do in fact lead to (or cause) the disease.

Quality Criteria Checklist: Primary Research
Relevance Questions
  1. Would implementing the studied intervention or procedure (if found successful) result in improved outcomes for the patients/clients/population group? (Not Applicable for some epidemiological studies) Yes
  2. Did the authors study an outcome (dependent variable) or topic that the patients/clients/population group would care about? Yes
  3. Is the focus of the intervention or procedure (independent variable) or topic of study a common issue of concern to dieteticspractice? Yes
  4. Is the intervention or procedure feasible? (NA for some epidemiological studies) ???
 
Validity Questions
1. Was the research question clearly stated? Yes
  1.1. Was (were) the specific intervention(s) or procedure(s) [independent variable(s)] identified? Yes
  1.2. Was (were) the outcome(s) [dependent variable(s)] clearly indicated? Yes
  1.3. Were the target population and setting specified? Yes
2. Was the selection of study subjects/patients free from bias? Yes
  2.1. Were inclusion/exclusion criteria specified (e.g., risk, point in disease progression, diagnostic or prognosis criteria), and with sufficient detail and without omitting criteria critical to the study? Yes
  2.2. Were criteria applied equally to all study groups? Yes
  2.3. Were health, demographics, and other characteristics of subjects described? Yes
  2.4. Were the subjects/patients a representative sample of the relevant population? Yes
3. Were study groups comparable? Yes
  3.1. Was the method of assigning subjects/patients to groups described and unbiased? (Method of randomization identified if RCT) Yes
  3.2. Were distribution of disease status, prognostic factors, and other factors (e.g., demographics) similar across study groups at baseline? Yes
  3.3. Were concurrent controls or comparisons used? (Concurrent preferred over historical control or comparison groups.) Yes
  3.4. If cohort study or cross-sectional study, were groups comparable on important confounding factors and/or were preexisting differences accounted for by using appropriate adjustments in statistical analysis? Yes
  3.5. If case control study, were potential confounding factors comparable for cases and controls? (If case series or trial with subjects serving as own control, this criterion is not applicable.) N/A
  3.6. If diagnostic test, was there an independent blind comparison with an appropriate reference standard (e.g., "gold standard")? N/A
4. Was method of handling withdrawals described? N/A
  4.1. Were follow-up methods described and the same for all groups? N/A
  4.2. Was the number, characteristics of withdrawals (i.e., dropouts, lost to follow up, attrition rate) and/or response rate (cross-sectional studies) described for each group? (Follow up goal for a strong study is 80%.) N/A
  4.3. Were all enrolled subjects/patients (in the original sample) accounted for? N/A
  4.4. Were reasons for withdrawals similar across groups? N/A
  4.5. If diagnostic test, was decision to perform reference test not dependent on results of test under study? N/A
5. Was blinding used to prevent introduction of bias? ???
  5.1. In intervention study, were subjects, clinicians/practitioners, and investigators blinded to treatment group, as appropriate? N/A
  5.2. Were data collectors blinded for outcomes assessment? (If outcome is measured using an objective test, such as a lab value, this criterion is assumed to be met.) Yes
  5.3. In cohort study or cross-sectional study, were measurements of outcomes and risk factors blinded? No
  5.4. In case control study, was case definition explicit and case ascertainment not influenced by exposure status? N/A
  5.5. In diagnostic study, were test results blinded to patient history and other test results? N/A
6. Were intervention/therapeutic regimens/exposure factor or procedure and any comparison(s) described in detail? Were interveningfactors described? N/A
  6.1. In RCT or other intervention trial, were protocols described for all regimens studied? N/A
  6.2. In observational study, were interventions, study settings, and clinicians/provider described? N/A
  6.3. Was the intensity and duration of the intervention or exposure factor sufficient to produce a meaningful effect? N/A
  6.4. Was the amount of exposure and, if relevant, subject/patient compliance measured? N/A
  6.5. Were co-interventions (e.g., ancillary treatments, other therapies) described? N/A
  6.6. Were extra or unplanned treatments described? N/A
  6.7. Was the information for 6.4, 6.5, and 6.6 assessed the same way for all groups? N/A
  6.8. In diagnostic study, were details of test administration and replication sufficient? N/A
7. Were outcomes clearly defined and the measurements valid and reliable? ???
  7.1. Were primary and secondary endpoints described and relevant to the question? Yes
  7.2. Were nutrition measures appropriate to question and outcomes of concern? Yes
  7.3. Was the period of follow-up long enough for important outcome(s) to occur? ???
  7.4. Were the observations and measurements based on standard, valid, and reliable data collection instruments/tests/procedures? Yes
  7.5. Was the measurement of effect at an appropriate level of precision? N/A
  7.6. Were other factors accounted for (measured) that could affect outcomes? N/A
  7.7. Were the measurements conducted consistently across groups? Yes
8. Was the statistical analysis appropriate for the study design and type of outcome indicators? Yes
  8.1. Were statistical analyses adequately described and the results reported appropriately? Yes
  8.2. Were correct statistical tests used and assumptions of test not violated? Yes
  8.3. Were statistics reported with levels of significance and/or confidence intervals? Yes
  8.4. Was "intent to treat" analysis of outcomes done (and as appropriate, was there an analysis of outcomes for those maximally exposed or a dose-response analysis)? N/A
  8.5. Were adequate adjustments made for effects of confounding factors that might have affected the outcomes (e.g., multivariate analyses)? Yes
  8.6. Was clinical significance as well as statistical significance reported? ???
  8.7. If negative findings, was a power calculation reported to address type 2 error? N/A
9. Are conclusions supported by results with biases and limitations taken into consideration? Yes
  9.1. Is there a discussion of findings? Yes
  9.2. Are biases and study limitations identified and discussed? Yes
10. Is bias due to study's funding or sponsorship unlikely? Yes
  10.1. Were sources of funding and investigators' affiliations described? Yes
  10.2. Was the study free from apparent conflict of interest? Yes